Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1958 1
1962 1
1963 1
1965 2
1967 5
1968 1
1969 3
1970 1
1971 1
1972 2
1973 4
1974 4
1975 2
1976 1
1977 5
1978 8
1979 3
1980 3
1981 4
1982 2
1983 2
1984 4
1985 3
1986 6
1987 3
1988 9
1989 7
1990 5
1991 15
1992 12
1993 16
1994 12
1995 16
1996 14
1997 14
1998 20
1999 22
2000 31
2001 27
2002 37
2003 39
2004 47
2005 65
2006 66
2007 86
2008 134
2009 164
2010 131
2011 142
2012 178
2013 167
2014 187
2015 200
2016 202
2017 243
2018 296
2019 397
2020 449
2021 536
2022 274
Text availability
Article attribute
Article type
Publication date

Search Results

3,847 results
Results by year
Filters applied: . Clear all
Page 1
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, Áinle FN, Alomran F, Alayed K, Alsheef M, AlSumait F, Pompilio CE, Sperlich C, Tangri S, Tang T, Jaksa P, Suryanarayan D, Almarshoodi M, Castellucci LA, James PD, Lillicrap D, Carrier M, Beckett A, Colovos C, Jayakar J, Arsenault MP, Wu C, Doyon K, Andreou ER, Dounaevskaia V, Tseng EK, Lim G, Fralick M, Middeldorp S, Lee AYY, Zuo F, da Costa BR, Thorpe KE, Negri EM, Cushman M, Jüni P; RAPID trial investigators. Sholzberg M, et al. Among authors: tang t. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400. BMJ. 2021. PMID: 34649864 Free PMC article. Clinical Trial.
Heparin for Moderately Ill Patients with Covid-19.
Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, Ní Áinle F, Alomran F, Alayed K, Alsheef M, AlSumait F, Pompilio CE, Sperlich C, Tangri S, Tang T, Jaksa P, Suryanarayan D, Almarshoodi M, Castellucci L, James PD, Lillicrap D, Carrier M, Beckett A, Colovos C, Jayakar J, Arsenault MP, Wu C, Doyon K, Andreou ER, Dounaevskaia V, Tseng EK, Lim G, Fralick M, Middeldorp S, Lee AYY, Zuo F, da Costa BR, Thorpe KE, Negri EM, Cushman M, Jüni P; RAPID Trial investigators. Sholzberg M, et al. Among authors: tang t. medRxiv. 2021 Jul 12:2021.07.08.21259351. doi: 10.1101/2021.07.08.21259351. Preprint. medRxiv. 2021. PMID: 34268513 Free PMC article. Updated.
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia.
Le Q, Castro S, Tang T, Loeb AM, Hylkema T, McKay CN, Perkins L, Srivastava S, Call L, Smith J, Leonti A, Ries R, Pardo L, Loken MR, Correnti C, Fiorenza S, Turtle CJ, Riddell S, Tarlock K, Meshinchi S. Le Q, et al. Among authors: tang t. Clin Cancer Res. 2021 Oct 15;27(20):5718-5730. doi: 10.1158/1078-0432.CCR-21-1546. Epub 2021 Aug 11. Clin Cancer Res. 2021. PMID: 34380639
Caractéristiques et issues des hospitalisations pour les cas de COVID-19 et d’influenza dans la région de Toronto.
Verma AA, Hora T, Jung HY, Fralick M, Malecki SL, Lapointe-Shaw L, Weinerman A, Tang T, Kwan JL, Liu JJ, Rawal S, Chan TCY, Cheung AM, Rosella LC, Ghassemi M, Herridge M, Mamdani M, Razak F. Verma AA, et al. Among authors: tang t. CMAJ. 2021 Jun 7;193(23):E859-E869. doi: 10.1503/cmaj.202795-f. CMAJ. 2021. PMID: 34099474 Free PMC article. French.
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor.
Wang X, Allen S, Blake JF, Bowcut V, Briere DM, Calinisan A, Dahlke JR, Fell JB, Fischer JP, Gunn RJ, Hallin J, Laguer J, Lawson JD, Medwid J, Newhouse B, Nguyen P, O'Leary JM, Olson P, Pajk S, Rahbaek L, Rodriguez M, Smith CR, Tang TP, Thomas NC, Vanderpool D, Vigers GP, Christensen JG, Marx MA. Wang X, et al. Among authors: tang tp. J Med Chem. 2022 Feb 24;65(4):3123-3133. doi: 10.1021/acs.jmedchem.1c01688. Epub 2021 Dec 10. J Med Chem. 2022. PMID: 34889605 Free article.
The long and short of it.
Passmore LA, Tang TT. Passmore LA, et al. Among authors: tang tt. Elife. 2021 Jul 2;10:e70757. doi: 10.7554/eLife.70757. Elife. 2021. PMID: 34213415 Free PMC article.
Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data.
Anwar M, Chen Q, Ouyang D, Wang S, Xie N, Ouyang Q, Fan P, Qian L, Chen G, Zhou E, Guo L, Gu X, Ding B, Yang X, Liu L, Deng C, Xiao Z, Li J, Wang Y, Zeng S, Hu J, Zhou W, Qiu B, Wang Z, Weng J, Liu M, Li Y, Tang T, Wang J, Zhang H, Dai B, Tang W, Wu T, Xiao M, Li X, Liu H, Li L, Yi W. Anwar M, et al. Among authors: tang t. Clin Cancer Res. 2021 Aug 15;27(16):4634-4641. doi: 10.1158/1078-0432.CCR-21-0474. Epub 2021 Jun 10. Clin Cancer Res. 2021. PMID: 34112711
3,847 results